What is Avacta DX working on?14 Jun 2023 09:08
Noting a 200%+ increase for Aptamer Group on the announcement that they are to develop an LFT for early detection of Alzheimer’s Disease…
Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, and Neuro-Bio, an Oxford-based biotechnology company with a therapeutic focus on neurodegenerative disease, announce success in the development of Optimer binders to enable a lateral flow test for the early diagnosis of Alzheimer's disease.
Come on Sir Al, what are those little affimers detecting that’s monetisable? Surely it can’t be too difficult to develop a test to reveal all the aluminium and glyphosate particles that we’re breathing in daily?